More rigour needed in trials of new diagnostic agents for tuberculosis
Lancet
.
2000 Sep 23;356(9235):1048-9.
doi: 10.1016/S0140-6736(00)02724-0.
Authors
P M Small
1
,
M D Perkins
Affiliation
1
Division of Infectious Diseases and Geographic Medicine, Stanford University Medical Center, California, USA.
PMID:
11009137
DOI:
10.1016/S0140-6736(00)02724-0
No abstract available
Publication types
Comment
MeSH terms
Clinical Trials as Topic
Humans
Mycobacterium tuberculosis / immunology
Tuberculosis / diagnosis*
Tuberculosis / immunology